Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 14, 2022
- Accession no.
- 0001447362-22-000152
- Filed
- Sep 14, 2022
- Trade date
- Sep 12-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 21 non-derivative transactions. Open-market sales total $262.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 | Common Stock | SSaleDisposed | −2,994 | $29.56F2 | −$88,502.64 | 309,120 | Direct | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −1,464 | $29.56F2 | −$43,275.84 | 139,018 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −1,367 | $29.56F2 | −$40,408.52 | 126,886 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −293 | $29.56F2 | −$8,661.08 | 28,236 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −293 | $29.56F2 | −$8,661.08 | 28,234 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −293 | $29.56F2 | −$8,661.08 | 28,234 | Indirect | |
| Sep 12, 2022 | Common Stock | SSaleDisposed | −293 | $29.56F2 | −$8,661.08 | 28,232 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −685 | $27.67F9 | −$18,953.95 | 308,435 | Direct | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −335 | $27.67F9 | −$9,269.45 | 138,683 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −312 | $27.67F9 | −$8,633.04 | 126,574 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −66 | $27.67F9 | −$1,826.22 | 28,170 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −67 | $27.67F9 | −$1,853.89 | 28,167 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −67 | $27.67F9 | −$1,853.89 | 28,167 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −68 | $27.67F9 | −$1,881.56 | 28,164 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −172 | $28.40F10 | −$4,884.8 | 308,263 | Direct | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −84 | $28.40F10 | −$2,385.6 | 138,599 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −79 | $28.40F10 | −$2,243.6 | 126,495 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −17 | $28.40F10 | −$482.8 | 28,153 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −17 | $28.40F10 | −$482.8 | 28,150 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −17 | $28.40F10 | −$482.8 | 28,150 | Indirect | |
| Sep 13, 2022 | Common Stock | SSaleDisposed | −16 | $28.40F10 | −$454.4 | 28,148 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $29.11 to $30.00, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $27.35 to $28.34, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $28.35 to $28.49, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.